/
/
/

Mangalam Drugs And Organics Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
₹57 Cr₹67 Cr₹58 Cr₹50 Cr₹57 Cr₹73 Cr₹89 Cr₹80 Cr₹77 Cr₹102 Cr₹97 Cr
₹11 L₹9 L₹11 L₹3 L₹14 L₹47 L₹14 L₹14 L₹2 L₹5 L₹20,000
₹57 Cr₹67 Cr₹59 Cr₹50 Cr₹57 Cr₹73 Cr₹89 Cr₹80 Cr₹77 Cr₹102 Cr₹97 Cr
₹60 Cr₹78 Cr₹64 Cr₹57 Cr₹66 Cr₹68 Cr₹84 Cr₹75 Cr₹72 Cr₹94 Cr₹94 Cr
₹1 Cr-₹6 Cr-₹1 Cr-₹3 Cr-₹4 Cr₹10 Cr₹9 Cr₹9 Cr₹8 Cr₹12 Cr₹7 Cr
₹4 Cr₹3 Cr₹4 Cr₹5 Cr₹4 Cr₹4 Cr₹3 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr
-₹7 Cr-₹13 Cr-₹10 Cr-₹12 Cr-₹13 Cr₹2 Cr₹1 Cr₹1 Cr₹59 L₹4 Cr₹4 L
-₹8 Cr-₹13 Cr-₹10 Cr-₹7 Cr-₹14 Cr₹6 L₹1 Cr₹3 Cr₹3 Cr₹4 Cr₹50 L

Share Price Live Stats

Open (₹)30.90
Volume (₹)18,726.00
High (₹)30.90
Upper Circuit33.33
Low (₹)29.90
Lower Circuit27.27
Prev Close30.30
52W High (₹)79.70
Price30.00
52W Low (₹)22.80

Share Market Cap & Key Ratios Overview

M.Cap (₹)48.24 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.62
Price to Book0.83
Book Value89.65
EPS (TTM)-24.16
Face Value10.00
ROE (%)4.84

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
MANGALAMNSE
LTP
1W Low
1W High
Market cap (₹)
1963+34 (1.76%)
1881.80
2183.80
4,56,833Cr
9555+390 (4.26%)
8750
10010
2,45,426Cr
4857-108.5 (-2.19%)
4711.50
5252.50
1,87,320Cr
1119.9-47.9 (-4.10%)
1086.40
1230
1,13,217Cr
1499+76 (5.34%)
1300
1523.50
1,12,212Cr
1784.8-76.8 (-4.13%)
1697.20
2024
1,01,155Cr
2321+168 (7.80%)
2004.50
2321
97,626Cr
2560.6+204.1 (8.66%)
2317
2560.60
96,859Cr
1279.8+108.8 (9.29%)
1151
1279.80
96,406Cr
1653.1-30.2 (-1.79%)
1603.50
1818.40
93,614Cr
30+0.14 (0.47%)
29.06
32.50
48Cr

Key Highlights of Mangalam Drugs And Organics Ltd’s P&L

In 2025-03-31, Mangalam Drugs And Organics Ltd reported total revenue of ₹318.73Cr, compared with ₹368.71Cr in 2024-03-31, reflecting Mangalam Drugs And Organics Ltd turnover.

Depreciation was ₹16.61Cr and finance costs were ₹14.93Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹4.79Cr in 2025-03-31 as compared to ₹-₹11.07Cr in 2024-03-31.

Net Profit (PAT) was ₹6.72Cr in 2025-03-31 compared with ₹-₹9.07Cr in 2024-03-31.

Earnings per share (EPS) were ₹4.25 in 2025-03-31, compared with ₹-5.73 in 2024-03-31.